Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
2021 · Drug Resistance Updates · 360 citations
https://doi.org/10.1016/j.drup.2020.100742
Y
Yehuda G. Assaraf
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
309
Papers
21.3K
Citations
80
h-index
220
i10-index
Yehuda G. Assaraf is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Folate and B Vitamins Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 80, co-authored 263 publications.
ORCID: 0000-0001-6692-8221Papers by this author
worksThe role of alternative splicing in cancer: From oncogenesis to drug resistance
2020 · Drug Resistance Updates · 302 citations
https://doi.org/10.1016/j.drup.2020.100728
Therapeutic strategies to overcome taxane resistance in cancer
2021 · Drug Resistance Updates · 217 citations
https://doi.org/10.1016/j.drup.2021.100754
Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression
2004 · Journal of Biological Chemistry · 125 citations
https://doi.org/10.1074/jbc.m401725200
Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance
2009 · Neoplasia · 116 citations
https://doi.org/10.1593/neo.91314
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
2012 · Cell Death and Disease · 98 citations
https://doi.org/10.1038/cddis.2012.30
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat